Phenytoin-induced alterations in craniofacial gene expression

Teratology

Volumn 59, Issue 1, 1999, Pages 23-34

  Gelineau Van Waes, Janee ^a   Bennett, Gregory D ^a   Finnell, Richard H ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LAMININ; MESSENGER RNA; PHENYTOIN; RETINOIC ACID RECEPTOR; SOMATOMEDIN B; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; DEVELOPMENTAL GENETICS; EMBRYO; FEMALE; GENE EXPRESSION; MORPHOGENESIS; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

ABNORMALITIES, DRUG-INDUCED; ANIMALS; ANTICONVULSANTS; DNA, COMPLEMENTARY; EMBRYONIC AND FETAL DEVELOPMENT; FACE; FEMALE; GENE EXPRESSION; MICE; MICE, INBRED STRAINS; MORPHOGENESIS; PHENYTOIN; PREGNANCY; RECEPTORS, RETINOIC ACID; SKULL;

EID: 0032990542     PISSN: 00403709     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9926(199901)59:1<23::AID-TERA7>3.0.CO;2-M     Document Type: Article

References (73)

1. Abbott BD, Birnbaum LS. 1990. Retinoic acid-induced alterations in the expression of growth factors in embryonic mouse palatal shelves. Teratology 42:597-610.
2. Audouin-Chevallier I, Pallet V, Coustaut M, Alfos S, Higueret P, Garcin H. 1995. Retinoids modulate the binding capacity of the glucocorticoid receptor and its translocation from cytosol to nucleus in liver cells. J Steroid Biochem Mol Biol 52:321-328.
3. Azarbayjani F, Danielsson BR. 1998. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: A common teratogenic mechanism for antiepileptic drugs? Teratology 57:117-126.
4. Baulieu EE, Kelly PA. 1990. Regulation of hormone receptors. In: Baulieu EE, Kelly PA, editors. Hormones. New York: Hermann Publishers, p 8.
5. Bennett GD, Lau F, Calvin JA, Finnell RH. 1997. Phenytoin-induced teratogenesis: A molecular basis for the observed delay during neurulation. Epilepsia 38:415-423.
6. Castren E, da Penha Berzaghi M, Lindholm D, Thoenen H. 1993. Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain. Exp Neurol 122:244-252.
7. Chambon P. 1994. The retinoid signaling pathway: Molecular and genetic analyses. Cell Biol 5:115-125.
8. Coustaut M, Pallet V, Garcin H, Higueret P. 1996. The influence of dietary vitamin A on triiodothyronine, retinoic acid, and glucocorticoid receptors in liver of hypothyroid rats. Br J Nutr 76:295-306.
9. Crowe TC, Loidl NM, Payne KL, Topliss DJ, Stockigt JR, Barlow JW. 1996. Differential modulation of thyroid hormone responsiveness by retinoids in a human cell line. Endocrinology 137:3187-3192.
10. Dansky LV, Finnell RH. 1991. Parental epilepsy, anticonvulsant drugs and reproductive outcome: Epidemiological and experimental findings spanning three decades. II. Human studies. Reprod Toxicol 5:281-99.
11. Davies JA. 1995. Mechanisms of action of antiepileptic drugs. Seizure 4:267-271.
12. Dony C, Kessel M, Gruss P. 1985. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9. Nature 317:636-639.
13. Dziadek M, Timpl R. 1985. Expression of nidogen and laminin in basement membranes during mouse embryogenesis and in teratocarcinoma cells. Dev Biol 111:372-382.
14. Eberwine JH, Spencer CM, Miyashiro K, Mackler SA, Finnell RH. 1992a. cDNA synthesis in situ: In: Methods in enzymology. New York: New York Press. p 80-100.
15. Eberwine JH, Yeh H, Miyashiro K, Cao Y, Nair S, Finnell R, Zettel M, Coleman P. 1992b. Analysis of gene expression in single live neurons. Proc Natl Acad Sci USA 89:3010-3014.
16. Ericsson UB, Bjerre I, Forsgren M, Ivarsson SA. 1985. Thyroglobulin and thyroid hormones in patients on long-term treatment with phenytoin, carbamazepine, and valproic acid. Epilepsia 26:594-596.
17. Ferguson MW, Sharpe PM, Thomas BL, Beck F. 1992. Differential expression of insulin-like growth factors I and II (IGF I and II), mRNA, peptide and binding protein 1 during mouse palate development: Comparison with TGF beta peptide distribution. J Anat 181:219-238.
18. Fex G, Larsson K, Anderson A, Berggren-Soderlund M. 1995. Low serum concentration of all-trans and 13-cis retinoic acids in patients treated with phenytoin, carbamazepine and valproate: Possible relation to teratogenicity. Arch Toxicol 69:572-574.
19. Finnell RH. 1981. Phenytoin-induced teratogenesis: A mouse model. Science 211:483-484.
20. Finnell RH, Chernoff GF. 1987. Gene-teratogen interactions: An approach to understanding the metabolic basis of birth defects. In: Nau H, Scott WJ, editors. Drug disposition in teratogenesis, volume II. New York: CRC Press, p 97-112.
21. Finnell RH, Kerr BM, van Waes M, Steward RL, Levy RH. 1994. Protection from phenytoin-induced congenital malformations by co-administration of the antiepileptic drug stiripentol in a mouse model. Epilepsia 35:131-148.
22. Finnell RH, Nau H, Yerby MS. 1995. Teratogenicity of antiepileptic drugs. In: Levy RH, Mattson RH, Meldrum BS, editors. Antiepileptic drugs. Volume 4. New York: Raven Press, p 209-230.
23. Franklyn JA, Davis JR, Ramsden DB, Sheppard MC. 1985. Phenytoin and thyroid hormone action. J Endocrinol 104:201-204.
24. Friedman A, Halevy O, Schrift M, Arazi Y, Sklan D. 1993. Retinoic acid promotes proliferation and induces expression of retinoic acid receptor-alpha gene in murine T-lymphocytes. Cell Immunol 152: 240-248.
25. Giguere V. 1994. Retinoic acid receptors and cellular retinoid binding proteins: Complex interplay in retinoid signaling. Endocr Rev 15: 61-79.
26. Goldman AS. 1984. Biochemical mechanism of glucocorticoid and phenytoin-induced cleft palate. Curr Top Dev Biol 19:217-239.
27. Goldman AS, van Dyke DC, Gupta C, Katsumata M. 1987. Elevated glucocorticoid receptor levels in lymphocytes of children with the fetal hydantoin syndrome (FHS). Am J Med Genet 28:607-618.
28. Gupta C, Katsumata M, Goldman AS. 1984. H-2 influences phenytoin binding and inhibition of prostaglandin synthesis. Immunogenetics 20:667-676.
29. Gupta C, Katsumata M, Goldman AS. 1985. H-2 histocompatibility region influences the inhibition of arachidonic acid cascade by dexamethasone and phenytoin in mouse embryonic palates. J Craniofac Genet Dev Biol 5:277-285.
30. Gwag BJ, Springer JE. 1993. Activation of NMDA receptors increases brain-derived neurotrophic factor (BDNF) mRNA expression in the hippocampal formation. Neuroreport 5:125-128.
31. Halazonetis TD, Georgopoulos K, Greenberg ME, Leder P. 1988. c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities. Cell 55:917-924.
32. Halevy O, Arazi Y, Melamed D, Friedman A, Sklan D. 1994. Retinoic acid receptor-alpha gene expression is modulated by dietary vitamin A and by retinoic acid in chicken T-lymphocytes. J Nutr 124: 2139-46.
33. Hanson JW, Smith DW. 1975. The fetal hydantoin syndrome. J Pediatr 87:285-290.
34. Hanson JW, Myrianthopoulos NC, Harvey MA, Smith DW. 1976. Risks to offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr 89:662-668.
35. Heine UI, Munoz EF, Flanders KC, Ellingsworth LR, Lam HY, Thompson NL, Roberts AB, Sporn MB. 1987. Role of transforming growth factor-β in the development of the mouse embryo. J Cell Biol 105:2861-2876.
36. Hierck BP, Thorsteinsdottir S, Niessen CM, Freund E, Iperen LV, Feyen A, Hogervorst F, Poelmann RE, Mummery CL, Sonnenberg A. 1993. Variations of the alpha 6 beta 1 laminin receptor in early murine development: Distribution, molecular cloning and chromosomal localization of the mouse integrin alpha 6 subunit. Cell Adhes Commun 1:33-53.
37. Hughes P, Dragunow M, Beilharz E, Lawlor P, Gluckman P. 1993. MK801 induces immediate-early gene proteins and BDNF mRNA in rat cerebrocortical neurones. Neuroreport 4:183-186.
38. Hughes PE, Young D, Preston KM, Yan Q, Dragunow M. 1998. Differential regulation by MK801 of immediate-early genes, brainderived neurotrophic factor and trk receptor mRNA induced by a kindling after-discharge. Brain Res Mol Brain Res 53:138-151.
39. Inayoshi K, Ohsaki Y, Nagata K, Kurisu K. 1989. The relation between phenytoin-receptor and glucocorticoid in the induction of cleft palate with phenytoin in mice. Shika Kiso Igakkai Zasshi 31:718-723.
40. Kato S, Mano H, Kumazawa T, Yoshizawa Y, Kojima R, Masushige S. 1992. Effect of retinoid status on alpha, beta and gamma retinoic acid receptor mRNA levels in various rat tissues. Biochem J 286:755-760.
41. Katsumata M, Gupta C, Goldman AS. 1985. Glucocorticoid receptor 1B: Mediator of anti-inflammatory and teratogenic functions of both glucocorticoids and phenytoin. Arch Biochem Biophys 243:385-395.
42. Kay ED, Goldman AS, Daniel JC. 1990. Common biochemical pathway of dysmorphogenesis in murine embryos: Use of the glucocorticoid pathway by phenytoin. Teratogenesis Carcinog Mutagen 10:31-39.
43. Kocchar DM, Penner JD, Tellone CI. 1984. Comparative teratogenic activities of two retinoids: Effects on palate and limb development. Teratogenesis Carcinog Mutagen 4:377-387.
44. Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT, Curry CJ, Fernhoff PM, Grix AW Jr., Lott IT. 1985. Retinoic acid embryopathy. N Engl J Med 313:837-841.
45. Larkin JG, Macphee GJ, Beastall GH, Brodie MJ. 1989. Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacol 36:213-216.
46. Lohnes D, Mark M, Mendelsohn C, Dolle P, Dierich A, Gorry P, Gansmuller A, Chambon P. 1994. Function of the retinoic acid receptors (RARs) during development (1) craniofacial and skeletal abnormalities in RAR double mutants. Development 120:2723-2748.
47. Lohnes D, Mark M, Mendelsohn C, Dolle P, Decimo D, LeMeur M, Dierich A, Gorry P, Chambon P. 1995. Developmental roles of the retinoic acid receptors. J Steroid Biochem Mol Biol 53:475-586.
48. Macdonald RL, Kelly KM. 1995. Antiepileptic drug mechanisms of action. Epilepsia [Suppl] 36:2-12.
49. Mahmood R, Flanders KC, Morriss-Kay GM. 1995. The effects of retinoid status on TGF beta expression during mouse embryogenesis.Anat Embryol (Berl) 192:21-33.
50. Matsumoto K, Gaetano C, Daughaday WH, Thiele CJ. 1992. Retinoic acid regulates insulin-like growth factor II expression in a neuroblastoma cell line. Endocrinology 130:3669-3676.
51. Morriss-Kay G. 1993. Retinoic acid and craniofacial development: Molecules and morphogenesis. Bioessays 15:9-15.
52. Musselman AC, Bennett GD, Greer KA, Eberwine JH, Finnell RH. 1994. Phenytoin-induced alterations of early embryonic gene expression. Reprod Toxicol 8:383-395.
53. Nau H, Tzimas G, Mondry M, Plum C, Spohr HL. 1995. Antiepileptic drugs alter endogenous retinoid concentrations: A possible mechanism of teratogenesis of anticonvulsant therapy. Life Sci 57:53-60.
54. Peterson PE, Blankenship TN, Wilson DB, Hendrickx AG. 1996. Analysis of hindbrain neural crest migration in the long-tailed monkey (Macaca fascicularis). Anat Embryol (Berl) 194:235-246.
55. Probert AW, Borosky S, Marcoux FW, Taylor CP. 1997. Sodium channel modulators prevent oxygen and glucose deprivation injury and glutamate release in rat neocortical cultures. Neuropharmacology 36:1031-1038.
56. Rivey MP, Schottelius DD, Berg MJ. 1984. Phenytoin-folic acid: A review. Drug Intell Clin Pharm 18:292-301.
57. Ross EM, Gilman AG. 1985. Mechanisms of drug action. In: Gilman AG, Goodman TW, editors. The pharmacological basis of therapeutics, 7th ed. New York: MacMillan Publishing Co. p 35-48.
58. Rossino P, Defilippi P, Silengo L, Tarone G. 1991. Up-regulation of the integrin alpha 1/beta 1 in human neuroblastoma cells differentiated by retinoic acid: Correlation with increased neurite outgrowth response to laminin. Cell Regul 2:1021-1033.
59. Salomon DS, Pratt RM. 1979. Involvement of glucocorticoids in the development of the secondary palate. Differentiation 13:141-154.
60. Scita G, Darwiche N, Greenwald E, Rosenberg M, Politi K, DeLuca LM. 1996. Retinoic acid down-regulation of fibronectin and retinoic acid receptor alpha proteins in NIH-3T3 cells. Blocks of this response by ras transformation. J Biol Chem 271:6502-6508.
61. Smith DW. 1980. Hydantoin effects on the fetus. In: Hassell TM, Johnston MC, Dudley KH, editors. Phenytoin-induced teratology and gingival pathology. New York: Raven Press, p 35-40.
62. Snell GD, Fekete E, Hummel KP. 1948. The relation of mating, ovulation and the estrus smear in the house mouse to the time of day. Anat Rec 76:30-54.
63. Song LN. 1994. Effects of retinoic acid and dexamethasone on proliferation, differentiation, and glucocorticoid receptor expression in cultured human osteosarcoma cells. Oncol Res 6:111-118.
64. Takeyama K, Kojima R, Ohashi R, Sato T, Mano H, Masushige S, Kato S. 1996. Retinoic acid differentially up-regulates the gene expression of retinoic acid receptor alpha and gamma isoforms in embryo and adult rats. Biochem Biophys Res Commun 222:395-400.
65. Theiler K. 1989. The house mouse: Atlas of embryonic development. New York: Springer-Verlag, p 98-101.
66. Thorogood P, Smith L. 1984. Neural crest cells: The role of extracellular matrix in their differentiation and migration. Prog Clin Biol Res 151:171-185.
67. Ueno T, Suita S, Zaizen Y. 1993. Retinoic acid induces insulin-like growth factor II expression in a neuroblastoma cell line. Cancer Lett 71:177-182.
68. Wamil AW, McLean MJ. 1993. Phenytoin blocks N-methyl-D-aspartate responses of mouse central neurons. J Pharmacol Exp Ther 267: 218-227.
69. Wells PG, Harbison RD. 1980. Significance of the phenytoin reactive arene oxide intermediate, its oxepin tautomer, and clinical factors modifying their roles in phenytoin-induced teratology. In: Hassell TM, Johnston MC, Dudley KH, editors. Phenytoin-induced teratology and gingival pathology. New York: Raven Press. p 35-40.
70. Wells PG, Winn LM. 1996. Biochemical toxicology of chemical teratogenesis. Crit Rev Biochem Mol Biol 31:1-40.
71. Wells PG, Zubovits JT, Wong ST, Molinari LM, Ali S. 1989. Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid and alpha-phenyl-N-t-butylnitrone: Implications for bioactivation by prostaglandin synthetase. Toxicol Appl Pharmacol 97:192-202.
72. Wilson JG, Roth CB, Warkany J. 1953. An analysis of the syndrome of malformations induced by maternal vitamin A deficiency. Effects of restoration of vitamin A at various times during gestation. Am J Anat 92:189-217.
73. Wlodarczyk B, Bennett GD, Calvin JA, Craig JC, Finnell RH. 1996. Arsenic-induced alterations in embryonic transcription factor gene expression: Implications for abnormal neural development. Dev Genet 18:306-315.